SES

Non-Factor Replacement Product Test System

Product code
SES
Device name
Non-Factor Replacement Product Test System
Device class
Class 2
21 CFR
21 CFR 864.7298
Medical specialty
Hematology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
0 (direct download)
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

A non-factor replacement product test system is a prescription in vitro diagnostic device intended to measure non-factor replacement therapeutic products that are indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with bleeding disorders, including hemophilia, in human blood specimens to ensure appropriate therapy in accordance with the approved non-factor replacement product labeling.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2025-05-22.

NumberDecision dateApplicantDevice nameSummary
DEN2400352025-05-22Randox Laboratories, Ltd.ConcizuTrace™ ELISA
Official FDA classification page: SES
Classification and pathway per current FDA publications. Data from openFDA (CC0).